The Venn diagram identified JAK2 as the target gene of BW18 in AML through intersecting the predicted targets of BW18 with the targets of AML from different databases (Figure 6A and Supplementary Table S4). This evidence concerns the gene JAK2 and acute myeloid leukemia.